Arkolith/Insider Trading/KLRS/Form 4

Hagen Brett R

Chief Accounting OfficerKalaris Therapeutics, Inc. (KLRS) · full profile →Form 4 · filed Mar 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 20, 2026Sell(S)2K$6.72$13K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 19, 2026Grant(A)61K—$061K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-119707) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML